跳至主要内容
临床试验/NCT07604220
NCT07604220招募中不适用

Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2026年7月13日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
115
试验地点
2

研究概览

简要总结

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults ≥18 years.
  • Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.
  • Undergoing FDG-PET as part of standard care.
  • Ability to provide informed consent.

排除标准

  • Inability to provide informed consent.

研究组 & 干预措施

Cardiac Sarcoidosis Patients

Patients with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.

干预措施: Exosome Analysis (Other)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew N Rosenbaum

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验